The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
Open accessAbstract
Aicardi–Goutières syndrome is an inflammatory disease occurring due to mutations in any of TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR or IFIH1. We report on 374 patients from 299 families with mutations in these seven genes. Most patients conformed to one of two fairly stereotyped clinical profiles; either exhibiting an in utero disease‐onset (74 patients; 22.8% of all patients where data were available), or a post‐natal presentation, usually within the first year of life (223 patients; 68.6%), characterized by a sub‐acute encephalopathy and a loss of previously acquired skills. Other clinically distinct phenotypes were also observed; particularly, bilateral striatal necrosis (13 patients; 3.6%) and non‐syndromic spastic paraparesis (12 patients; 3.4%). We recorded 69 deaths (19.3% of patients with follow‐up data). Of 285 patients for whom data were available, 210 (73.7%) were profoundly disabled, with no useful motor, speech and intellectual function. Chilblains, glaucoma, hypothyroidism, cardiomyopathy, intracerebral vasculitis, peripheral neuropathy, bowel inflammation and systemic lupus erythematosus were seen frequently enough to be confirmed as real associations with the Aicardi‐Goutieres syndrome phenotype. We observed a robust relationship between mutations in all seven genes with increased type I interferon activity in cerebrospinal fluid and serum, and the increased expression of interferon‐stimulated gene transcripts in peripheral blood. We recorded a positive correlation between the level of cerebrospinal fluid interferon activity assayed within one year of disease presentation and the degree of subsequent disability. Interferon‐stimulated gene transcripts remained high in most patients, indicating an ongoing disease process. On the basis of substantial morbidity and mortality, our data highlight the urgent need to define coherent treatment strategies for the phenotypes associated with mutations in the Aicardi–Goutières syndrome‐related genes. Our findings also make it clear that a window of therapeutic opportunity exists relevant to the majority of affected patients and indicate that the assessment of type I interferon activity might serve as a useful biomarker in future clinical trials. © 2015 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07414.x · Cited by 6,721
Eliasson, A.-C., Krumlinde-Sundholm, L., Rösblad, B., Beckung, E., Arner, M., Öhrvall, A.-M., & Rosenbaum, P. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206001162 · Cited by 2,187
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationCrow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Self-citationHIDECKER, M. J. C., PANETH, N., ROSENBAUM, P. L., KENT, R. D., LILLIE, J., EULENBERG, J. B., CHESTER JR, K., JOHNSON, B., MICHALSEN, L., EVATT, M., et al. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03996.x · Cited by 879
Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2091 · Cited by 730 · cited 1×
“PatientswithbothAGSandSLEwerefirst describedover 14years ago [Aicardi and Goutieres, 2000; Dale et al., 2000], and heterozygous mutations in TREX1 have been identified in non-syndromic lupus [Lee-Kirsch et al., 2007].”
BackgroundRice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
Self-citationCrow, Y. J., Leitch, A., Hayward, B. E., Garner, A., Parmar, R., Griffith, E., Ali, M., Semple, C., Aicardi, J., Babul-Hirji, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1842 · Cited by 675
Self-citationRice, G. I., del Toro Duany, Y., Jenkinson, E. M., Forte, G. M. A., Anderson, B. H., Ariaudo, G., Bader-Meunier, B., Baildam, E. M., Battini, R., Beresford, M. W., et al. (2014) · Nature Genetics · doi:10.1038/ng.2933 · Cited by 591
Self-citationEliasson, A.-C., Krumlinde-Sundholm, L., Rösblad, B., Beckung, E., Arner, M., Öhrvall, A.-M., & Rosenbaum, P. (2007) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2006.tb01313.x · Cited by 540
Aicardi, J., & Goutières, F. (1984) · Annals of Neurology · doi:10.1002/ana.410150109 · Cited by 488
Reijns, M. A. M., Rabe, B., Rigby, R. E., Mill, P., Astell, K. R., Lettice, L. A., Boyle, S., Leitch, A., Keighren, M., Kilanowski, F., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.011 · Cited by 466
Richards, A., van den Maagdenberg, A. M. J. M., Jen, J. C., Kavanagh, D., Bertram, P., Spitzer, D., Liszewski, M. K., Barilla-LaBarca, M.-L., Terwindt, G. M., Kasai, Y., et al. (2007) · Nature Genetics · doi:10.1038/ng2082 · Cited by 445
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
Rice, G., Patrick, T., Parmar, R., Taylor, C. F., Aeby, A., Aicardi, J., Artuch, R., Montalto, S. A., Bacino, C. A., Barroso, B., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521373 · Cited by 445
Self-citationRice, G. I., Forte, G. M. A., Szynkiewicz, M., Chase, D. S., Aeby, A., Abdel-Hamid, M. S., Ackroyd, S., Allcock, R., Bailey, K. M., Balottin, U., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70258-8 · Cited by 443
Self-citationRice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationType I interferonopathies: a novel set of inborn errors of immunity
Crow, Y. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06220.x · Cited by 404
Self-citationAicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity
Crow, Y. J., & Rehwinkel, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp293 · Cited by 289
Self-citationEvaluation of the TREX1 gene in a large multi-ancestral lupus cohort
Namjou, B., Kothari, P. H., Kelly, J. A., Glenn, S. B., Ojwang, J. O., Adler, A., Alarcón-Riquelme, M. E., Gallant, C. J., Boackle, S. A., Criswell, L. A., et al. (2011) · Genes & Immunity · doi:10.1038/gene.2010.73 · Cited by 281
Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy
Lebon, P., Badoual, J., Ponsot, G., Goutières, F., Hémeury-Cukier, F., & Aicardi, J. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90125-6 · Cited by 236
Self-citationClifford, R., Louis, T., Robbe, P., Ackroyd, S., Burns, A., Timbs, A. T., Wright Colopy, G., Dreau, H., Sigaux, F., Judde, J. G., et al. (2014) · Blood · doi:10.1182/blood-2013-04-490847 · Cited by 230
Self-citationType I interferonopathies: Mendelian type I interferon up-regulation
Crow, Y. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.005 · Cited by 190
Self-citationA type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1
Livingston, J. H., Lin, J., Dale, R. C., Gill, D. S., Brogan, P. A., Münnich, A., Kurian, M. A., González, V., Goede, C. G. E. L. D., Falconer, A., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102038 · Cited by 175
Self-citationRamesh, V., BERNARDI, B., Stafa, A., Garone, C., Franzonı, E., Abinun, M., Mitchell, P. D., Mitra, D., Friswell, M., Nelson, J. W., et al. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03727.x · Cited by 120
Self-citationHomozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke
Xin, B., Jones, S., Puffenberger, E. G., Hinze, C. H., Bright, A., Tan, H., Zhou, A., Wu, G., Vargus‐Adams, J. N., Agamanolis, D. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014265108 · Cited by 112
Crow, Y. J., Black, D. N., Ali, M., Bond, J., Jackson, A. P., Lefson, M., Michaud, J., Roberts, E., Stephenson, J. B. P., Woods, C. G., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.3.183 · Cited by 111
Self-citationTherapies in Aicardi–Goutières syndrome
Crow, Y. J., Vanderver, A. L., Orcesi, S., Kuijpers, T. W., & Rice, G. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12115 · Cited by 97
Self-citationDale, R. C., Gornall, H., Singh‐Grewal, D., Alcausin, M. B., Rice, G., & Crow, Y. J. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33359 · Cited by 94
Self-citationTolmie, J., Shillito, P., Hughes-Benzie, R., & Stephenson, J. B. P. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.11.881 · Cited by 91
Mutations in ADAR1, IFIH1, and RNASEH2B Presenting As Spastic Paraplegia
Zaki, M. S., Abdel‐Hamid, M., Abdel‐Salam, G. M. H., Boespflug‐Tanguy, O., Cordeiro, N., Gleeson, J. G., Gowrinathan, N., Laugel, V., Renaldo, F., Rodriguez, D., et al. (2014) · Neuropediatrics · doi:10.1055/s-0034-1389161 · Cited by 90
Self-citationThiele, H., du Moulin, M., Barczyk, K., George, C., Schwindt, W., Nürnberg, G., Frosch, M., Kurlemann, G., Roth, J., Nürnberg, P., et al. (2010) · Human Mutation · doi:10.1002/humu.21357 · Cited by 74
Familial Systemic Lupus Erythematosus and Congenital Infection-Like Syndrome
Dale, R. C., Tang, S. P., Heckmatt, J. Z., & Tatnall, M. F. (2000) · Neuropediatrics · doi:10.1055/s-2000-7492 · Cited by 65
Self-citationInterferon and Aicardi-Goutières syndrome
Lebon, P., Meritet, J. F., Krivine, A., & Rozenberg, F. (2002) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2002.0574 · Cited by 55
Self-citationSystemic Lupus Erythematosus or Aicardi-Goutières Syndrome?
Aicardi, J. F., & Goutières, F. (2000) · Neuropediatrics · doi:10.1055/s-2000-7533 · Cited by 53
Abe, J., Nakamura, K., Nishikomori, R., Kato, M., Mitsuiki, N., Izawa, K., Awaya, T., Kawai, T., Yasumi, T., Toyoshima, I., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket372 · Cited by 43
Congenital glaucoma and brain stem atrophy as features of Aicardi–Goutières syndrome
Crow, Y. J., Massey, R., Innes, J., Pairaudeau, P., Hill, C. A. R., Woods, C. G., Ali, M., Livingston, J. H., Lebon, P., Nischal, K. K., et al. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30250 · Cited by 39
Self-citationRare Variants in theTREX1Gene and Susceptibility to Autoimmune Diseases
Barizzone, N., Monti, S. M., Mellone, S., Godi, M., Marchini, M., Scorza, R., Danieli, M. G., & D’Alfonso, S. (2013) · BioMed Research International · doi:10.1155/2013/471703 · Cited by 36
Vogt, J., Agrawal, S., Ibrahim, Z., Southwood, T. R. E., Philip, S., MacPherson, L. K. R., Bhole, M. V., Crow, Y. J., & Oley, C. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35712 · Cited by 32
Self-citationOlivieri, I., Cattalini, M., Tonduti, D., Piana, R. L., Uggetti, C., Galli, J., Meini, A., Tincani, A., Moratto, D., Fazzi, E. M., et al. (2013) · Lupus · doi:10.1177/0961203313498800 · Cited by 27
Self-citationRice, G., Reijns, M. A. M., Coffin, S. R., Forte, G., Anderson, B., Szynkiewicz, M., Gornall, H., Gent, D. G., Leitch, A., Botella, M. P., et al. (2013) · Human Mutation · doi:10.1002/humu.22336 · Cited by 25
Self-citation
Cited by
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925
Self-citationMitochondrial DNA in inflammation and immunity
Riley, J. S., & Tait, S. W. (2020) · EMBO reports · doi:10.15252/embr.201949799 · Cited by 865
Management strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
Discriminating self from non-self in nucleic acid sensing
Schlee, M., & Hartmann, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.78 · Cited by 593
Metadata
- Authors
- Crow, Y. J., Chase, D. S., Lowenstein Schmidt, J., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., Oojageer, A., Anderson, B., Pizzino, A., Helman, G., Abdel‐Hamid, M. S., Abdel‐Salam, G. M., Ackroyd, S., Aeby, A., Agosta, G., Albin, C., Allon‐Shalev, S., Arellano, M., Ariaudo, G., Aswani, V., Babul‐Hirji, R., Baildam, E. M., Bahi‐Buisson, N., Bailey, K. M., Barnerias, C., Barth, M., Battini, R., Beresford, M. W., Bernard, G., Bianchi, M., Billette de Villemeur, T., Blair, E. M., Bloom, M., Burlina, A. B., Luisa Carpanelli, M., Carvalho, D. R., Castro‐Gago, M., Cavallini, A., Cereda, C., Chandler, K. E., Chitayat, D. A., Collins, A. E., Sierra Corcoles, C., Cordeiro, N. J. V., Crichiutti, G., Dabydeen, L., Dale, R. C., D′Arrigo, S., De Goede, C. G. E. L., De Laet, C., De Waele, L. M. H., Denzler, I., Desguerre, I., Devriendt, K., Di Rocco, M., Fahey, M. C., Fazzi, E., Ferrie, C. D., Figueiredo, A., Gener, B., Goizet, C., Gowrinathan, N. R., Gowrishankar, K., Hanrahan, D., Isidor, B., Kara, B., Khan, N., King, M. D., Kirk, E. P., Kumar, R., Lagae, L., Landrieu, P., Lauffer, H., Laugel, V., Piana, R. L., Lim, M. J., Lin, J. S. ‐., Linnankivi, T., Mackay, M. T., Marom, D. R., Marques Lourenço, C., McKee, S. A., Moroni, I., Morton, J. E. V., Moutard, M., Murray, K., Nabbout, R., Nampoothiri, S., Nunez‐Enamorado, N., Oades, P. J., Olivieri, I., Ostergaard, J. R., Pérez‐Dueñas, B., Prendiville, J. S., Ramesh, V., Rasmussen, M., Régal, L., Ricci, F., Rio, M., Rodriguez, D., Roubertie, A., Salvatici, E., Segers, K. A., Sinha, G. P., Soler, D., Spiegel, R., Stödberg, T. I., Straussberg, R., Swoboda, K. J., Suri, M., Tacke, U., Tan, T. Y., te Water Naude, J., Wee Teik, K., Mary Thomas, M., Till, M., Tonduti, D., Maria Valente, E., Noel Van Coster, R., van der Knaap, M. S., Vassallo, G., Vijzelaar, R., Vogt, J., Wallace, G. B., Wassmer, E., Webb, H. J., Whitehouse, W. P., Whitney, R. N., Zaki, M. S., Zuberi, S. M., Livingston, J. H., Rozenberg, F., Lebon, P., Vanderver, A., Orcesi, S., & Rice, G. I.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2015-01-16
- Volume
- 167
- Issue
- 2
- Pages
- 296-312
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2063675796
- Cited by
- 595
- References
- 41
- FWCI
- 22.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.